Refining Prediction in Treatment-Resistant Depression: Results of Machine Learning Analyses in the TRD III Sample

被引:57
作者
Kautzky, Alexander [1 ]
Dold, Markus [1 ]
Bartova, Lucie [1 ]
Spies, Marie [1 ]
Vanicek, Thomas [1 ]
Souery, Daniel [2 ,3 ]
Montgomery, Stuart [4 ]
Mendlewicz, Julien [5 ]
Zohar, Joseph [6 ]
Fabbri, Chiara [7 ]
Serretti, Alessandro [7 ]
Lanzenberger, Rupert [1 ]
Kasper, Siegfried [1 ]
机构
[1] Med Univ Vienna, Dept Psychiat & Psychotherapy, Wahringer Gurtel 18-20, A-1090 Vienna, Austria
[2] Univ Libre Bruxelles, Brussels, Belgium
[3] Psy Pluriel Ctr Europeen Psychol Med, Brussels, Belgium
[4] Univ London, Imperial Coll, London, England
[5] Free Univ Brussels, Sch Med, Brussels, Belgium
[6] Chaim Sheba Med Ctr, Div Psychiat, Ramat Gan, Israel
[7] Univ Bologna, Dept Biomed & Neuromotor Sci, Bologna, Italy
关键词
SUBSTANCE USE DISORDERS; MAJOR DEPRESSION; EUROPEAN MULTICENTER; RATING-SCALE; OPEN-LABEL; STRATEGIES; SYMPTOMS; NONRESPONDERS; IMPROVEMENT; DULOXETINE;
D O I
10.4088/JCP.16m11385
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Objective: The study objective was to generate a prediction model for treatment-resistant depression (TRD) using machine learning featuring a large set of 47 clinical and sociodemographic predictors of treatment outcome. Method: 552 Patients diagnosed with major depressive disorder (MDD) according to DSM-IV criteria were enrolled between 2011 and 2016. TRD was defined as failure to reach response to antidepressant treatment, characterized by a Montgomery-Asberg Depression Rating Scale (MADRS) score below 22 after at least 2 antidepressant trials of adequate length and dosage were administered. RandomForest (RF) was used for predicting treatment outcome phenotypes in a 10-fold cross-validation. Results: The full model with 47 predictors yielded an accuracy of 75.0%. When the number of predictors was reduced to 15, accuracies between 67.6% and 71.0% were attained for different test sets. The most informative predictors of treatment outcome were baseline MADRS score for the current episode; impairment of family, social, and work life; the timespan between first and last depressive episode; severity; suicidal risk; age; body mass index; and the number of lifetime depressive episodes as well as lifetime duration of hospitalization. Conclusions: With the application of the machine learning algorithm RF, an efficient prediction model with an accuracy of 75.0% for forecasting treatment outcome could be generated, thus surpassing the predictive capabilities of clinical evaluation. We also supply a simplified algorithm of 15 easily collected clinical and sociodemographic predictors that can be obtained within approximately 10 minutes, which reached an accuracy of 70.6%. Thus, we are confident that our model will be validated within other samples to advance an accurate prediction model fit for clinical usage in TRD.
引用
收藏
页数:9
相关论文
共 62 条
  • [51] The measurement of disability
    Sheehan, DV
    HarnettSheehan, K
    Raj, BA
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1996, 11 : 89 - 95
  • [52] Reliability and Validity of the Mini International Neuropsychiatric Interview for Children and Adolescents (MINI-KID)
    Sheehan, David V.
    Sheehan, Kathy H.
    Shytle, R. Douglas
    Janavs, Juris
    Bannon, Yvonne
    Rogers, Jamison E.
    Milo, Karen M.
    Stock, Saundra L.
    Wilkinson, Berney
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2010, 71 (03) : 313 - 326
  • [53] Treatment resistant depression: methodological overview and operational criteria
    Souery, D
    Amsterdam, J
    de Montigny, C
    Lecrubier, Y
    Montgomery, S
    Lipp, O
    Racagni, G
    Zohar, J
    Mendlewicz, J
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 1999, 9 (1-2) : 83 - 91
  • [54] Clinical factors associated with treatment resistance in major depressive disorder: Results from a European multicenter study
    Souery, Daniel
    Oswald, Pierre
    Massat, Isabelle
    Bailer, Ursula
    Bollen, Joseph
    Demyttenaere, Koen
    Kasper, Siegfried
    Lecrubier, Yves
    Montgomery, Stuart
    Serretti, Alessandro
    Zohar, Joseph
    Mendlewicz, Julien
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2007, 68 (07) : 1062 - 1070
  • [55] Souery D, 2006, J CLIN PSYCHIAT, V67, P16
  • [56] Thase ME, 1997, J CLIN PSYCHIAT, V58, P23
  • [57] Relationship Between Obesity and Depression: Characteristics and Treatment Outcomes With Antidepressant Medication
    Toups, Marisa S. P.
    Myers, Alyson K.
    Wisniewski, Stephen R.
    Kurian, Benji
    Morris, David W.
    Rush, Augustus John
    Fava, Maurizio
    Trivedi, Madhukar H.
    [J]. PSYCHOSOMATIC MEDICINE, 2013, 75 (09): : 863 - 872
  • [58] Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: Implications for clinical practice
    Trivedi, MH
    Rush, AJ
    Wisniewski, SR
    Nierenberg, AA
    Warden, D
    Ritz, L
    Norquist, G
    Howland, RH
    Lebowitz, B
    McGrath, PJ
    Shores-Wilson, K
    Biggs, MM
    Balasubramani, GK
    Fava, M
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2006, 163 (01) : 28 - 40
  • [59] Estimating remission from untreated major depression: a systematic review and meta-analysis
    Whiteford, H. A.
    Harris, M. G.
    McKeon, G.
    Baxter, A.
    Pennell, C.
    Barendregt, J. J.
    Wang, J.
    [J]. PSYCHOLOGICAL MEDICINE, 2013, 43 (08) : 1569 - 1585
  • [60] Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010
    Whiteford, Harvey A.
    Degenhardt, Louisa
    Rehm, Juergen
    Baxter, Amanda J.
    Ferrari, Alize J.
    Erskine, Holly E.
    Charlson, Fiona J.
    Norman, Rosana E.
    Flaxman, Abraham D.
    Johns, Nicole
    Burstein, Roy
    Murray, Christopher J. L.
    Vos, Theo
    [J]. LANCET, 2013, 382 (9904) : 1575 - 1586